yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q26774097-407AD37D-BE1C-4AC8-8F07-E4271DDEEBFA
Q26774097-407AD37D-BE1C-4AC8-8F07-E4271DDEEBFA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26774097-407AD37D-BE1C-4AC8-8F07-E4271DDEEBFA
Eribulin in the Management of Advanced Breast Cancer: Implications of Current Research Findings
P2860
Q26774097-407AD37D-BE1C-4AC8-8F07-E4271DDEEBFA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26774097-407AD37D-BE1C-4AC8-8F07-E4271DDEEBFA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
66a5124fab8fe878fe5ffa21ab03764c8e159bed
P2860
Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer.